David J. Monsma
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 2
- Biotechnology top 10%
- Cancer Research and Treatments 4
-
- Cancer Cells and Metastasis 5
- Colorectal Cancer Treatments and Studies 3
- CAR-T cell therapy research 2
- Cancer Treatment and Pharmacology 2
-
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Judith A. MarlettCraig P. WebbNicholas W. VollendorfDavid CherbaGilbert S. OmennDavid E. MisekJ A MarlettSamir Hanash
- Cited by
- Cancer ResearchBiotechnologyOncology
- Partner nations
- United StatesPakistan
In The Last Decade
David J. Monsma
16 papers receiving 385 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 100
- Biotechnology 49
- Oncology 145
- Nutrition and Dietetics 57
- Molecular Biology 188
Countries citing papers authored by David J. Monsma
This map shows the geographic impact of David J. Monsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Monsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Monsma more than expected).
Fields of papers citing papers by David J. Monsma
This network shows the impact of papers produced by David J. Monsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Monsma. The network helps show where David J. Monsma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David J. Monsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 19 | |
| 2 | 2018 | 10 | |
| 3 | 2015 | 20 | |
| 4 | Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. | 2015 | 21 |
| 5 | 2015 | 1 | |
| 6 | 2015 | 0 | |
| 7 | 2014 | 16 | |
| 8 | Establishment of genetically diverse patient-derived xenografts of colorectal cancer. | 2014 | 25 |
| 9 | 2012 | 55 | |
| 10 | 2010 | 36 | |
| 11 | 2009 | 17 | |
| 12 | 2007 | 26 | |
| 13 | 2005 | 57 | |
| 14 | 2000 | 20 | |
| 15 | 1996 | 25 | |
| 16 | 1995 | 19 | |
| 17 | 1992 | 25 |
About David J. Monsma
David J. Monsma is a scholar working on Biotechnology, Cancer Research and Oncology, having authored 17 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer Research and Treatments (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Sarcoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (100 citations), Biotechnology (49 citations) and Oncology (145 citations). David J. Monsma has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Judith A. Marlett, Craig P. Webb, Nicholas W. Vollendorf, David Cherba, Gilbert S. Omenn, David E. Misek, J A Marlett, Samir Hanash, Noel R. Monks and Rork Kuick. Their work appears in journals such as Journal of Nutrition, Journal of Translational Medicine, Blood, Molecular Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.